Deutsch English Français

Contact

EP1542987

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1542987

EP1542987 - PIPERIDINE-N-OXIDE-DERIVATIVES [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 16.06.2006 Database last updated on 19.10.2024
Most recent event Tooltip	16.06.2006	Application deemed to be withdrawn	published on 19.07.2006 [2006/29]
Applicant(s)	For all designated states ALTANA Pharma AG Byk-Gulden-Strasse 2 78467 Konstanz / DE
	[2005/25]
Inventor(s)	01 / STERK, Geert, Jan Stadhouderslaan 38 NL-3583 JJ Utrecht / NL
	02 / HATZELMANN, Armin Alter Wall 3 78467 Konstanz / DE
	03 / BARSIG, Johannes Bleichenweg 11 78467 Konstanz / DE
	04 / MARX, Degenhard Obere Reute 15 78345 Moos / DE
	05 / KLEY, Hans-Peter Im Weinberg 3b 78476 Allensbach / DE
	06 / BRUNDEL, Paulus, Johannes, Gaurerius v. Brakelstraat 51 A NL-3814 RJ Amersfoort / NL
	07 / CHRISTIAANS, Johannes, A., M. Zevenwouden 233 NL-3524 CR Utrecht / NL
	08 / MENGE, Wiro, M., P., B. Pontanuslaan 11 NL-6821 HM Arnhem / NL
	[2005/25]
Representative(s)	Wild, Robert, et al Takeda GmbH Postfach 10 03 10 78403 Konstanz / DE
	[N/P]
Former [2005/25]	Wild, Robert, et al c/o ALTANA Pharma AG, Byk-Gulden-Strasse 2 78467 Konstanz / DE
Application number, filing date	03792258.0	06.08.2003
	[2005/25]
	WO2003EP08676
Priority number, date	EP20020017978	10.08.2002 Original published format: EP 02017978
	[2005/25]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2004018450
	Date:	04.03.2004
	Language:	EN
	[2004/10]
	Type:	A1 Application with search report
	No.:	EP1542987
	Date:	22.06.2005
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 04.03.2004 takes the place of the publication of the European patent application.
	[2005/25]
Search report(s)	International search report - published on:	EP	04.03.2004
Classification	IPC:	C07D401/04, C07D405/14, A61K31/50	[2005/25]
	CPC:	C07D401/04 (EP,US); A61P11/00 (EP); C07D405/14 (EP,US)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/25]
Extension states	AL	10.03.2005
	LT	10.03.2005
	LV	10.03.2005
	MK	10.03.2005
Title	German:	PIPERIDIN-N-OXIDDERIVATE	[2005/25]
	English:	PIPERIDINE-N-OXIDE-DERIVATIVES	[2005/25]
	French:	DERIVES DE N-OXYDE DE PIPERIDINE	[2005/25]
Entry into regional phase	10.03.2005	National basic fee paid
	10.03.2005	Designation fee(s) paid
	10.03.2005	Examination fee paid
Examination procedure	17.02.2004	Request for preliminary examination filed International Preliminary Examining Authority: EP
	10.03.2005	Examination requested [2005/25]
	14.07.2005	Despatch of a communication from the examining division (Time limit: M06)
	25.01.2006	Application deemed to be withdrawn, date of legal effect [2006/29]
	02.03.2006	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2006/29]
Fees paid	Renewal fee
	12.08.2005	Renewal fee patent year 03
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[PAD]WO02085906 (ALTANA PHARMA AG [DE], et al) [PAD] 1-17 * page 31 - page 41; claims 1-13 *;
		[PAD]WO02064584 (BYK GULDEN LOMBERG CHEM FAB [DE], et al) [PAD] 1-17 * page 25 - page 36; claims 1-13 *;
		[YD]WO9931090 (BYK GULDEN LOMBERG CHEM FAB [DE], et al) [YD] 1-17 * page 34 - page 38; claims 1-10 *;
		[YD]WO0130777 (BYK GULDEN LOMBERG CHEM FAB [DE], et al) [YD] 1-17 * page 21 - page 25; claims 1-10 *;
		[YD]WO9931071 (BYK GULDEN LOMBERG CHEM FAB [DE], et al) [YD] 1-17 * page 32 - page 36; claims 1-10 *;
		[YD]WO9831674 (BYK GULDEN LOMBERG CHEM FAB [DE], et al) [YD] 1-17 * page 49 - page 55; claims 1-10 *;
		[YD]WO9307146 (SYNTEX INC [US]) [YD] 1-17 * page 162 - page 169; claims 1-33 *;
		[DY] - MARGARETHA VAN DER MEY ET AL., "Novel Selective Phosphodiesterase (PDE4) inhibitors. 4. Resolution, Absolute Configuration and PDE4 Inhibitory Activity of cis-Tetra- and cis-Hexahydrophathalazinones", JOURNAL OF MEDICINAL CHEMISTRY., AMERICAN CHEMICAL SOCIETY., US, (20020606), vol. 45, no. 12, ISSN 0022-2623, pages 2526 - 2533, XP002262562 [DY] 1-17 * the whole document * DOI: http://dx.doi.org/10.1021/jm0110338
		[DY] - MARGARETHA VAN DER MEY ET AL., "Novel Selective PDE4 Inhibitors.3. In Vivo Antiinflammatory Activity of a New Series of N-Substituted cis-Tetra- and cis-Hexahydrophthalazinones", JOURNAL OF MEDICINAL CHEMISTRY., AMERICAN CHEMICAL SOCIETY., US, (20020606), vol. 45, no. 12, ISSN 0022-2623, pages 2520 - 2525, XP002262563 [DY] 1-17 * the whole document * DOI: http://dx.doi.org/10.1021/jm0110340
		[DY] - MARGARETHA VAN DER MEY ET AL., "Novel Selective PDE4 Inhibitors. 2. Synthesis and Structure-Activity Relationships of 4-Aryl-Substituted cis-Tetra- and Cis-Hexahydrophthalazinones", JOURNAL OF MEDICINAL CHEMISTRY., AMERICAN CHEMICAL SOCIETY., US, (20010802), vol. 44, no. 16, ISSN 0022-2623, pages 2523 - 2535, XP002222951 [DY] 1-17 * the whole document * DOI: http://dx.doi.org/10.1021/jm010838c

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p